Delivery Order SPE2DB22D2211-SPE2DB24FMSX9

Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,130.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 14, 2022. Amerisourcebergen Drug Corp is an experienced pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award summarized here is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,222.73 and was awarded on April 1, 2022, with an ultimate completion date of April 4, 2022. This contract is a delivery order under a larger Indefinite Delivery...
This federal contract award is for the delivery of 4,559,457,678 units of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,573.55 fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 28, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract award, valued at $1,214.38, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract, valued at $10,623.96, is a Firm Fixed Price Delivery Order that runs through April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025,...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $1,703.80 and a performance period through March 19, 2024. It is not associated with any set-aside...
This federal contract award, valued at $12,975.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,559,450,627 units of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The contract has an ultimate completion date of December 27, 2022 and is structured as a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through...
This federal contract award, valued at $3,358.65, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,667,015 units of Oseltamivir Phos 75 mg Capsule UD 10s, a pharmaceutical product. The contract has a ceiling value of $3,358.65 and is a delivery order contract with a firm fixed price pricing type. The contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,732.12 firm fixed-price delivery order is for the supply of 4,558,866,552 units of the drug Oseltamivir Phosphate 30 mg capsules, with an ultimate completion date of October 25, 2022. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,019.23 to supply Oseltamivir Phosphate 75 mg capsules to support military treatment programs and facilities. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FMSX9
    Delivery Order

This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $1,406.83 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 10:24 AM